Inventor
THOMAS LAWRENCE J
US11 patents
⚠️ This page may combine multiple inventors who share the name “THOMAS LAWRENCE J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLDEX THERAPEUTICS INC
5 patentsUS10633444B2Apr 28, 2020
Agonistic antibodies that bind CD40
CELLDEX THERAPEUTICS INC12 citations91
US11180566B2Nov 23, 2021
Antibodies that bind human CD27 and uses thereof
CELLDEX THERAPEUTICS INC4 citations71
US10941201B2Mar 9, 2021
Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies
CELLDEX THERAPEUTICS INC2 citations70
US10865244B2Dec 15, 2020
Nucleic acids encoding agonistic antibodies that bind CD40
CELLDEX THERAPEUTICS INC1 citations70
US12297266B2May 13, 2025
Agonistic antibodies that bind human CD40 and uses thereof
CELLDEX THERAPEUTICS INC0 citations60
AVANT IMMUNOTHERAPEUTICS INC
4 patentsUS6284533B1Sep 4, 2001
Plasmid-based vaccine for treating atherosclerosis
AVANT IMMUNOTHERAPEUTICS INC75 citations94
US6555113B1Apr 29, 2003
Modulation of cholesteryl ester transfer protein (CETP) activity
AVANT IMMUNOTHERAPEUTICS INC12 citations73
US6846808B1Jan 25, 2005
Plasmid-based vaccine for treating atherosclerosis
AVANT IMMUNOTHERAPEUTICS INC7 citations72
US7078036B2Jul 18, 2006
Modulation of cholesteryl ester transfer protein (CETP) activity
AVANT IMMUNOTHERAPEUTICS INC0 citations51